Ren-tao Wang
Beijing, 100853, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum to "PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation" [Pharmacol. Res. (2023) 106636 / PMID: 36586643].
Journal: Pharmacological research
Published: September 19, 2025
Effectiveness and Safety of Anlotinib-Related Therapeutic Regimens in Patients with Previously Immune Checkpoint Inhibitors-Treated Advanced NSCLC: A Real-World Exploratory Study.
Journal: Drug design, development and therapy
Published: April 20, 2025
Downregulation of pro-surfactant protein B contributes to the recurrence of early-stage non-small cell lung cancer by activating PGK1-mediated Akt signaling.
Journal: Experimental hematology & oncology
Published: June 19, 2023
PD-L1 upregulation promotes drug-induced pulmonary fibrosis by inhibiting vimentin degradation.
Journal: Pharmacological research
Published: July 27, 2022
SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9-Mediated GSK3β/β-Catenin Signaling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 20, 2022
miR-150-5p Inhibits Non-Small-Cell Lung Cancer Metastasis and Recurrence by Targeting HMGA2 and β-Catenin Signaling.
Journal: Molecular therapy. Nucleic acids
Published: January 14, 2019
miR-124 Inhibits Lung Tumorigenesis Induced by K-ras Mutation and NNK.
Journal: Molecular therapy. Nucleic acids
Published: May 22, 2017
Decreased expression of miR216a contributes to non-small-cell lung cancer progression.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 25, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026